| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 08/08/2006 | CA2188835C Novel compounds and methods for synthesis and therapy |
| 08/03/2006 | WO2006080401A1 Method for producing fluorinated proline derivative |
| 08/03/2006 | WO2006032893A3 Trityl derivatives for enhancing mass spectrometry |
| 08/03/2006 | WO2005113011A3 Prodrugs of ion channel modulating compounds and uses thereof |
| 08/03/2006 | US20060173195 Process for preparing 4-aminomethyl-3-alkoxyiminopyrrolidine methanesulfonate |
| 08/03/2006 | US20060173194 Method for crystallizing N-vinyl-2-pyrrolidone |
| 08/03/2006 | US20060173188 Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 08/03/2006 | US20060173075 P-(sulfonyl) aryl and heteroarylamines-as anti-inflammatory agents |
| 08/03/2006 | US20060173056 Proline derivatives and use thereof as drugs |
| 08/03/2006 | US20060173040 bactericide; derivatives of pseudopeptide Andrimid in which beta-phenylalanine amide is replaced by heteroaromatic or substituted aromatic amide; N-{(1S)-3-[((1S)-1-{[(3R,4S)-1,4-Dimethyl-2,5-dioxo-3-pyrrolidinyl]carbonyl}-2-methylpropyl)amino]-3-oxo-1-phenylpropyl}-2-pyridinecarboxamide; antibiotics |
| 08/03/2006 | US20060173004 1-(4-Benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives |
| 08/03/2006 | US20060172990 Antibacterial agents |
| 08/03/2006 | US20060172950 Hepatitis C virus inhibitors |
| 08/03/2006 | CA2594915A1 Phenyl-substituted pyrrolidones |
| 08/03/2006 | CA2593816A1 Synthesis of aryl pyrrolidones |
| 08/02/2006 | EP1686130A1 Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents |
| 08/02/2006 | EP1685125A1 Pyrrol derivatives |
| 08/02/2006 | EP1685119A1 N-acylsulfonamide apoptosis promoters |
| 08/02/2006 | EP1685103A1 3-aminopyrrolidone derivatives |
| 08/02/2006 | EP1685102A1 Melanocortin receptor agonists |
| 08/02/2006 | EP1685101A1 N-acylated-3-(benzoyl)-pyrrolidines as 11-beta-hsd1 inhibitors useful for the treatment of metabolic disorders. |
| 08/02/2006 | EP1685094A1 Acylurea connected and sulfonylurea connected hydroxamates |
| 08/02/2006 | EP1562611B1 Heterocyclic silicon compounds and their use in the treatment of diseases or conditions associated with gnrh (gonadotropin-releasing hormone) |
| 08/02/2006 | EP1395242B1 Liquid pharmaceutical composition |
| 08/02/2006 | EP1072576B1 Fluorinating agent, process for producing the same, and use thereof |
| 08/02/2006 | EP1014966B1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 08/02/2006 | CN1812983A Substituted pyrrole derivatives and their use as hmg-co inhibitors |
| 08/02/2006 | CN1812970A Process for producing nitrogenous heterocyclic compound |
| 08/02/2006 | CN1812963A N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease |
| 08/02/2006 | CN1812785A New effector conjugates, process for their production and their pharmaceutical use |
| 08/02/2006 | CN1810788A Compound and its synthesis process and application |
| 08/02/2006 | CN1810787A Prepn process of methyl pyrrolidine |
| 08/02/2006 | CN1267419C Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides |
| 08/02/2006 | CN1267417C Compound of fluorene class containing dual hetero atoms as well as its synthetic method and application |
| 08/01/2006 | US7084282 Process for preparing 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide |
| 08/01/2006 | US7084166 Such as 1,1-di-(N-benzyl-indol-3-yl)-1-butene; for drug resistant tumors |
| 08/01/2006 | US7084165 Monoamine reuptake inhibitors for treatment of CNS disorders |
| 08/01/2006 | US7084163 Applying to plants |
| 08/01/2006 | US7084154 Reducing pain |
| 08/01/2006 | US7084139 Cardiovascular disorders; anticoagulants; antitumor, anticancer agents; Alzheimer's disease; Parkinson's disease |
| 08/01/2006 | CA2360024C Process for the preparation of non-steroidal glucocorticoid receptor modulators |
| 08/01/2006 | CA2189456C Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 08/01/2006 | CA2135479C Styryl derivatives, their preparation and use as pde-iv inhibitors |
| 07/27/2006 | WO2006078619A1 Insecticidal heterocyclic 1,4-disubstituted benzene n-oxides |
| 07/27/2006 | WO2006077026A1 2, 5-disubstituted phenyl methanone derivatives as glycine transporter 1 (glyt-i) inhibitors for the treatment of neurological and neuropsychiatry disorders |
| 07/27/2006 | WO2006012642A3 Pyrrole derivatives as pharmaceutical agents |
| 07/27/2006 | WO2004033397A3 Activity-based probes, and methods of their preparation and use |
| 07/27/2006 | US20060167276 Clausenamide c5-hydroxyl derivatives and n-substituted derivatives, processes for their preparation, its composition and use |
| 07/27/2006 | US20060167275 Isomerization; crystallization |
| 07/27/2006 | US20060167268 2-(2-Amino-2-methylpropionylamino)-3-(2,6-difluoro-3-methylphenyl)methoxy propionic acid N-[5-(4-chlorophenyl)-3,3-dimethyl-1,1-dioxo-2,3-dihydroisothiazol-4-ylmethyl]-N-ethylamide; endogenous human growth hormone controller; non-peptidyl in nature, more metabolically stable |
| 07/27/2006 | US20060167263 Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 07/27/2006 | US20060167244 Polymerisation inhibitor |
| 07/27/2006 | US20060167081 Ep4 receptor agonists |
| 07/27/2006 | US20060167054 Tumor necrosis factor (TNF alpha) inhibitors for treatinginflammatory/infectious/autoimmune/proliferative diseases; anticancer/tumor/diabetic/arthritic agents |
| 07/27/2006 | US20060167049 Terphenly derivatives, preparation thereof, compositions containing same |
| 07/27/2006 | US20060166990 Novel aminobenzophenone compounds |
| 07/27/2006 | US20060166985 Pyrrolydin-2-one derivatives as inhibitors of thrombin and factor xa |
| 07/27/2006 | US20060166961 Cell adhesion inhibitors |
| 07/27/2006 | US20060166895 N-heterocyclic hydroxyethylamine compounds; human immunodeficiency virus (HIV) protease |
| 07/27/2006 | US20060166894 Ace-inhibitors having antioxidant and no-donor activity |
| 07/27/2006 | US20060166858 Gonane ring substituted with hydroxy group and alkylamide derivatives used for achieving sustained systemic concentrations of therapeutic or prophylactic GABA(gamma-aminobutyric acid)analogs following administration to animals |
| 07/27/2006 | US20060166118 Heterocycle-hydrazone based charge transport materials |
| 07/27/2006 | US20060165648 Compounds, compositions, and methods for controlling biofilms |
| 07/27/2006 | CA2601326A1 2,5-disubstituted phenyl methanone derivatives as glycine transporter 1(glyt-i) inhibitors for the treatment of neurological and neuropsychiatric disorders |
| 07/27/2006 | CA2593359A1 Direct compression formulation and process |
| 07/26/2006 | EP1683786A1 Vitamin d3 lactam derivative |
| 07/26/2006 | EP1682525A2 N-sulfonylaminocarbonyl containing compounds |
| 07/26/2006 | EP1682501A2 2-halogen-6-alkyl-phenyl substituted tetramic acid derivatives |
| 07/26/2006 | EP1682500A1 Process for the preparation of ccr-2 antagonist |
| 07/26/2006 | EP1682494A1 Aralkyl amines as cannabinoid receptor modulators |
| 07/26/2006 | EP1682145A1 1-alkylpiperazinyl-pyrrolidin-2,5-dione derivatives as adrenergic receptor antagonists |
| 07/26/2006 | EP1682120A2 Fused phenylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 07/26/2006 | EP0979817B1 Leukotriene a4 hydrolaze inhibitors |
| 07/26/2006 | CN1809534A Method of preparing a ring compound having two adjacent chiral centers |
| 07/26/2006 | CN1809345A Enalapril-nitroxyderivatives derivatives and related compounds as ACE inhibitors for the treatment of cardiovascular diseases |
| 07/26/2006 | CN1807411A Unsaturated five heterocycle compound for up-regulating bone formation protein BMP-2 expression activity |
| 07/26/2006 | CN1266152C Method for the production of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid |
| 07/26/2006 | CN1266129C New compounds having activity of lowing blood fat and cholesterol, their preparation method and pharmaceutical compositions containing them |
| 07/26/2006 | CN1266118C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides |
| 07/26/2006 | CN1266112C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/25/2006 | US7081524 O2-substituted 1-[(2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates |
| 07/20/2006 | WO2006076246A2 Phenylglycinamide derivatives useful as anticoagulants |
| 07/20/2006 | WO2006075778A1 Production method of optically active cyclohexane ether compounds |
| 07/20/2006 | WO2006075638A1 Novel heteroaryl derivative |
| 07/20/2006 | WO2006075226A1 11c-labeled benzyl-lactam compounds and their use as imaging agents |
| 07/20/2006 | WO2006037775A8 Enantiopure heterocyclic compound useful for the preparation of peptides which can be potentially used as medicaments |
| 07/20/2006 | WO2006026532A3 Methods of treatment of amyloidosis using substituted ethanolcyclicamine aspartyl protease inhibitors |
| 07/20/2006 | WO2006012499A3 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation |
| 07/20/2006 | WO2005121130A3 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 07/20/2006 | WO2005051895A8 Organic compounds |
| 07/20/2006 | US20060161020 2-(Benzoylamino-3-phenylpropylamino]acetamide derivatives prevent the formation of insoluble A beta |
| 07/20/2006 | US20060161006 Asymmetric urea compound and process for producing asymmetric compound by asymmetric conjugate addition reaction with the same as catalyst |
| 07/20/2006 | US20060160886 Chemical compounds |
| 07/20/2006 | US20060160885 Chemical compounds |
| 07/20/2006 | US20060160856 Diarylurea derivatives and their use as chloride channel blockers |
| 07/20/2006 | US20060160847 2,4-Dihalogen-6-(c2-c3alkyl)-phenyl substituted tetramic acid derivatives |
| 07/20/2006 | US20060160832 Nitrogen-containing aromatic derivatives |
| 07/20/2006 | US20060160825 1-(5-Benzenesulfonyl-indan-1-yl)-piperazine, used as selective serotonin receptor antagonists for treatment of nervous system and gastrointestinal disorders |
| 07/20/2006 | US20060160805 Thiotungstate analogues and uses thereof |
| 07/20/2006 | US20060160788 such as Rac-(2-isopropoxy-5-methanesulfonyl-phenyl)-[3-(4-trifluoromethyl-phenoxy)-pyrrolidin-1-yl]-methanone, having good glycine transporter inhibitory activity and useful for the treatment of nervous system disorders such as schizophrenia, cognitive impairment and Alzheimer's disease |